• Research/Demonstration Projects: No research on daily oral PrEP has taken place in Malawi. There is an ongoing trial of an ARV-containing vaginal ring, slated to release data in the next year. As of mid-2015, PrEP was not included in the PEPFAR-supported DREAMS initiative.
  • Drug Registration: Truvada is registered for treatment. It is not registered for prevention.
  • Policy/Regulatory: In Malawi’s National HIV Prevention Strategy 2015–2020, PrEP is a stated part of the comprehensive prevention package for MSM and serodiscordant couples but funding for PrEP has yet to be allocated.
  • Advocacy: Civil society is at the forefront of efforts to ensure a comprehensive response, including high quality ART for people living with HIV and incorporation of PrEP. See, for example, the poster Advocacy for More HIV Prevention Options for Women in Malawi.

News Spotlight